
Exploring Minimal Retroviral Vector Systems for Genetic Innovation

Retroviral vector systems are used for more than three decades for applications requiring a stable genetic modification of target cells. In recent years they have proven in several clinical trials their effectiveness for the treatment of different diseases.
Further Information: PDF
GWT-TUD GmbH; FB Sächsische PatentVerwertungsAgentur (SPVA)
Phone: +49 351 25933 120
Contact
Beate-Victoria Ermisch